High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer (September, 10.1038/s41467-022-32828-6, 2022) Marta Palafox , Laia Monserrat , Meritxell Bellet , Guillermo Villacampa , Abel Gonzalez-Perez , Mafalda Oliveira , Fara Braso-Maristany , Nusaibah Ibrahimi , Srinivasaraghavan Kannan , Leonardo Mina , Maria Teresa Herrera-Abreu , Andreu Odena , Monica Sanchez-Guixe , Marta Capelan , Analia Azaro , Alejandra Bruna , Olga Rodriguez , Marta Guzman , Judit Grueso , Cristina Viaplana , Javier Hernandez , Faye Su , Kui Lin , Robert B. Clarke , Carlos Caldas , Joaquin Arribas , Stefan Michiels , Alicia Garcia-Sanz , Nicholas C. Turner , Aleix Prat , Paolo Nuciforo , Rodrigo Dienstmann , Chandra S. Verma , Nuria Lopez-Bigas , Maurizio Scaltriti , Monica Arnedos , Cristina Saura , Violeta Serra NATURE COMMUNICATIONS(2022)
AI 理解论文
溯源树
样例